SUMMARY Percutaneous balloon dilatation of a stenosed Ionescu-Shiley bioprosthesis in the tricuspid valve position was performed twice in a 19 year old woman. On each occasion there was a considerable improvement in symptoms and haemodynamic fumction but the effect lasted for only a few months. When the valve was excised it showed no evidence of the previous balloon dilatations.
SUMMARY Percutaneous balloon dilatation of a stenosed Ionescu-Shiley bioprosthesis in the tricuspid valve position was performed twice in a 19 year old woman. On each occasion there was a considerable improvement in symptoms and haemodynamic fumction but the effect lasted for only a few months. When the valve was excised it showed no evidence of the previous balloon dilatations.
Case report
A 19 year old woman presented with a four month history of peripheral oedema, abdominal distension, breathlessness on exertion, and increasing lethargy. Her symptoms had progressed despite diuretic treatment. Soon after birth she had been found to have a ventricular septal defect with pulmonary valve stenosis. When she was six infective endocarditis developed on the tricuspid valve and this produced severe regurgitation. At operation the tricuspid valve was replaced with a 19 mm Bjork-Shiley prosthesis, the ventricular septal defect was closed with a patch, and the pulmonary stenosis was relieved with an outflow patch. Four A catheter with a 20 mm diameter balloon (Mansfield Scientific, Mansfield, MA) was introduced via the femoral vein. The balloon was centred through the prosthesis and inflated to maximum diameter on four occasions for 15-25 seconds (figure). During balloon inflation there was no fall in systemic arterial pressure, no impairment of consciousness, and no cyanosis-despite the fact that the interatrial and After the second procedure there was a 4 kg weight loss overnight as a result of considerable diuresis. The improvement in symptoms was maintained for six months before the symptoms and signs of right heart failure returned. Further balloon dilatation was thought unlikely to produce a lasting improvement in symptoms and the patient underwent reoperation. The right atrium contained a large organised thrombus (7 cm x 4 cm x 4 cm). When the tricuspid prosthesis was excised its leaflets were found to be very stiff with calcific vegetations on both atrial and ventricular surfaces. There was no cusp fusion and no evidence of damage from balloon dilatation. A St Jude prosthesis was implanted and recovery was uneventful.
Discussion
Percutaneous balloon dilatation was offered to this patient as an altemative to valve replacement because she was young and had already undergone tricuspid valve replacement twice. The aim was to produce acceptable palliation rather than permanent relief of the valve stenosis. If the effect of balloon dilatation had persisted, insertion of a mechanical prosthesis (necessitating oral anticoagulation) might have been delayed until after childbearing.
The mechanism of the partial relief of the obstruction is unclear. The leaflets of the bovine pericardial prosthesis were very stiff and balloon dilatation probably stretched or otherwise reduced the stiffness of the valve leaflets.
Balloon dilatation of a tricuspid valve prosthesis has been reported once before. Feit et al produced apparently successful palliation in a patient with a 31 mm Hancock porcine prosthesis.' Their patient was followed up for only one month and so it is not clear whether the benefit persisted. They noted a fall in right atrial pressure and an increase in cardiac index, whereas in our patient there was no change in cardiac index and we saw an increase in right ventricular end diastolic pressure rather than a fall in right atrial pressure after balloon dilatation.
McKay et al reported two patients who underwent balloon dilatation of an aortic valve bioprosthesis.2
The procedure was complicated by severe damage to the prosthesis and one patient died as a result. They suggest that contraindications to dilatation of prosthetic valves should include valve leaflet calcification, the presence of vegetations or thrombosis, and degenerative changes in the valve cusps. Lloyd et al reduced valvar gradients in three offive patients undergoing balloon dilatation of calcified stenotic bioprosthetic valves in right ventricle to pulmonary artery conduits but no follow up data were given.'
Our experience suggests that the role of balloon dilatation in the management of stenosed bioprosthetic valves will be limited. Although symptoms and haemodynamic finction may be improved, lasting benefit is unlikely. 
